PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

DarioHealth Corp.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from DarioHealth Corp.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Assets Ratio: Of every $100 the company owns, $33 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 92% of Healthcare companies in United States.
  • Shareholder Slice Ratio: Share count rose 437% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 85% of Healthcare companies in United States.

Where $100 of sales goes

$264Operating costs$14Interest$187Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-109.8×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 83% of Healthcare companies in United States.

Cash Locked Ratio

$19

For every $100 of sales, $19 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $46 tied up three years earlier.

Less money tied up than 59% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 3/3

Sales grew in 1 of the last 3 years; profit grew in 3 of 3.

Steadier than 69% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 19%

Sales fell 19% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-19% / -8%

In 3 years sales changed by -19% while total assets changed by -8%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-60.3×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 76% of Healthcare companies in United States.

Cash Cushion Ratio

−16%

Debt, after subtracting cash, equals 16% of its market value (net debt).

Lower than 82% of Healthcare companies in United States.

Tangible Assets Ratio

33%

Of every $100 the company owns, $33 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 92% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 75% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+437%

Share count rose 437% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 85% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

DarioHealth Corp. made a loss over the last year. DarioHealth Corp. owes $0.43 for every $1 it owns. DarioHealth Corp. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

DarioHealth Corp. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

0.67

The share price is 0.67 times DarioHealth Corp.'s book value per share, lower than 86% of Healthcare companies in United States.

Market cap

$37 M

The total market value of all of DarioHealth Corp.'s shares at today's price (share price × number of shares), smaller than 77% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$55 M

What DarioHealth Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$5.62

Net worth divided by the number of shares. The share price of $3.77 is 0.7 times this, which is the P/B above.

Return on equity (ROE)

-59.9%

DarioHealth Corp. lost 59.9% of its shareholders' money over the last year, lower than 57% of Healthcare companies in United States.

Owes vs Owns

0.43×

DarioHealth Corp. owes $0.43 for every $1 it owns (low), higher than 51% of Healthcare companies in United States.

Dividend yield

None

DarioHealth Corp. does not currently pay a dividend.

Revenue growth

-17%

Revenue fell 17% in the year to Dec 2025, and shrank 7% a year on average over 3 years.

Profit growth

Loss

DarioHealth Corp. made a loss in each of the last two years.

Profit margin

-186.6%

DarioHealth Corp. lost $187 for every $100 of revenue.

Interest cover

Not covered

DarioHealth Corp.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

DarioHealth Corp. had $6 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For DarioHealth Corp.: $37 M ÷ $55 M (30 Jun 2026) = 0.7.

What is DarioHealth Corp.'s return on equity?

DarioHealth Corp. lost 59.9% of its shareholders' money over the last year, lower than 57% of Healthcare companies in United States.

How much does DarioHealth Corp. owe compared with what it owns?

DarioHealth Corp. owes $0.43 for every $1 it owns (low), higher than 51% of Healthcare companies in United States.

Does DarioHealth Corp. pay a dividend?

No. DarioHealth Corp. does not currently pay a dividend.

Is DarioHealth Corp.'s revenue growing?

Revenue fell 17% in the year to Dec 2025, and shrank 7% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.